The headline for prescription drugs in 2026 was simple: “Out-of-pocket costs are capped at $2,100.” For millions of seniors, this sounded like a promise that they would never pay more than that amount for their medications. The reality, however, is buried in the complex “phases” and “tiers” of your specific Part D plan.
While the cap is real, the path to reaching it—and what counts toward it—is full of potholes. Insurers have responded to the new cap by shifting costs to the front of the year and tightening the rules on which drugs qualify. From surprise monthly bills to “excluded” weight loss drugs that don’t count toward your limit, here are five cost-sharing rules that are catching patients by surprise this year.
1. The “Deductible Cliff” ($615)
Many seniors assume the new $2,100 cap means their costs are spread evenly throughout the year. In reality, most plans still charge a Standard Deductible upfront, which has risen to $615 in 2026.
You walk into the pharmacy in January to pick up your regular maintenance meds and are hit with a $615 bill on day one. Until you pay this entire amount out-of-pocket, your plan pays nothing. For those on fixed incomes, this “January Cliff” destroys their post-holiday budget, as they must effectively pay the first two months of drug costs in a single transaction before their coverage actually kicks in.
2. The “Coinsurance” Shift (Tier 3)
For years, “Tier 3” drugs (preferred brands) usually came with a flat copay, like $45 or $47. In 2026, to manage the financial risk of the new cap, many plans have converted Tier 3 from a flat copay to a percentage-based coinsurance.
Instead of paying $45 for your brand-name inhaler or blood thinner, you are now charged 17% to 25% of the drug’s full retail price. If the drug costs $600, your share is suddenly $150. This shift makes monthly costs unpredictable, as retail prices fluctuate, and leaves seniors paying significantly more for the same prescriptions they took last year.
3. The “Excluded Drug” Cap Trap
The $2,100 out-of-pocket cap only applies to “covered Part D drugs.” It does not apply to drugs that are statutorily excluded from Medicare, most notably GLP-1 agonists (like Wegovy or Zepbound) when prescribed for weight loss.
A senior might spend $1,000 a month on a weight loss drug, believing they will hit their $2,100 cap by March and get the rest for free. In reality, none of that spending counts toward the cap. They will end the year having spent $12,000 out-of-pocket, with the insurance covering zero percent, because the drug is considered a “lifestyle” medication under current Medicare rules.
4. The “Smoothing” Bill (M3P) Confusion
The new Medicare Prescription Payment Plan (M3P) allows you to smooth your drug costs into monthly payments. However, this creates a new billing relationship: you owe the insurer, not the pharmacy.
Seniors who opt into M3P often expect the payments to be deducted from their Social Security check, like their Part B premium. They are surprised to receive a separate monthly bill in the mail from their drug plan. If they miss this bill—thinking it’s junk mail—the plan can terminate their participation in the smoothing program, forcing them to pay the full lump sum of their drug costs immediately at the pharmacy counter.
5. The “Biosimilar” Step Therapy
Plans are aggressively managing costs by removing brand-name biologics (like Humira or Enbrel) from the formulary in favor of “Biosimilars.” This is often enforced through “Step Therapy” rules.
You go to refill the brand-name biologic you have been stable on for years, and the claim is denied. The pharmacist tells you that you must “fail” on the cheaper biosimilar version first before the plan will cover the original. If you insist on the brand name without a successful appeal, you may be forced to pay the full “Non-Preferred” price, which can exceed $3,000 a month, with limited credit toward your annual cap.
Check Your “Tier” Status
The specific tier of your medication is no longer just a detail; it is the difference between a $40 copay and a $200 coinsurance charge. Log in to your plan’s portal today and check if your maintenance drugs have moved from Tier 2 to Tier 3 this year.
Did your copay jump this year for a drug you’ve taken for years? Leave a comment below—tell us the price difference!
You May Also Like…
- 5 Prescription Pricing Changes Affecting Seniors With Chronic Conditions
- 8 Prescription Refill Rules That Are Costing Retirees More in 2026
- Why the Same Prescription Jumps From $40 to $400 Without Warning — The Insurance Reset Behind It
- 7 Prescription Rules That Trigger Higher Copays
- 7 Prescription Price Increases Linked to Supplier Changes
Read the full article here
